Less Ads, More Data, More Tools Register for FREE

EMERGING MARKETS-Latam stocks gain on vaccine optimism, FX rally peters out

Mon, 23rd Nov 2020 19:16

* Mexican peso at below 20 per dollar for first time since
March
* Peru preps century bond issue
* MSCI Latam stocks index up over 7% in last two weeks

(Adds details, updates prices)
By Sruthi Shankar and Ambar Warrick
Nov 23 (Reuters) - Latin American stocks rose on Monday,
while currencies retreated from initial gains as progress
towards a coronavirus vaccine bolstered hopes for economic
activity to return to pre-pandemic levels.
Bourses in Brazil, Chile and Mexico
rose between 0.8% to 1.4%, tracking a rally in global equities
after AstraZeneca said its COVID-19 vaccine, cheaper to
make, easier to distribute and faster to scale-up than its
rivals, could be as much as 90% effective.
Emerging market assets were cheered by the simpler
distribution logistics for the vaccine. Countries such as Brazil
and India already have supply and manufacturing contracts in
place for the vaccine.
Positive vaccine news, coupled with the prospect of easy
monetary policy for the duration of the pandemic has greatly
benefited equities, with the MSCI's index of regional equities
adding more than 7% over the past two weeks.
But regional currencies came off initial gains as investors
were still uncertain about the timing of a vaccine, while the
economic ructions from the pandemic continued to show. A
resurgence of infections in Brazil - Latam's largest economy -
also dulled risk appetite.
The real fell about 1%, while the Chilean peso
fell more than 1%, tracking a slight decline in copper prices.

Losses in the Mexican peso and the Colombian peso
were mitigated by strength in oil markets.
The Mexican unit fell slightly after briefly trading
below 20 to a dollar for the first time since March.
Renewed carry trade interest and relatively higher interest
rates have seen the peso outperform most of its emerging market
peers this year.
"The immediate target is MXN19.80," Marc Chandler, chief
market strategist at Bannockburn Global Forex told clients in a
note.
"The high nominal rates (~4.28% on a one-month bill, or
cetes) and the broader gains among emerging market currencies
appear to be fueling the peso's gains."
Peru's sol edged lower as the country prepared a
century bond in dollars after authorizing the issuance of debt
of up to $4 billion to help rein in the country's coronavirus
outbreak and soften its economic impact.
The issuance comes days after newly appointed interim
President Francisco Sagasti told Reuters that Peru planned to
issue bonds in the near term to service the Andean nation's
"very high" fiscal deficit.
Argentine markets were closed for a holiday.
Key Latin American stock indexes and currencies:

Latest Daily % change
MSCI Emerging Markets 1218.90 0.8

MSCI LatAm 2164.80 0.1

Brazil Bovespa 107178.68 1.07

Mexico IPC 42357.27 1.08

Chile IPSA 4131.91 1.91

Colombia COLCAP 1246.99 0.58


Currencies Latest Daily % change
Brazil real 5.4451 -1.09

Mexico peso 20.1343 -0.18

Chile peso 772.7 -1.14

Colombia peso 3645.55 -0.40
Peru sol 3.604 -0.26




(Reporting by Sruthi Shankar in Bengaluru; editing by Emelia
Sithole-Matarise and Tom Brown)

Related Shares

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an ora...

28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant sa...

27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.